1. Home
  2. DTCK vs GOVX Comparison

DTCK vs GOVX Comparison

Compare DTCK & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Davis Commodities Limited

DTCK

Davis Commodities Limited

HOLD

Current Price

$0.33

Market Cap

12.3M

Sector

Industrials

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.33

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCK
GOVX
Founded
1999
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
12.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
DTCK
GOVX
Price
$0.33
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
606.7K
547.9K
Earning Date
04-30-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$132,369,000.00
$3,353,560.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.52
52 Week Low
$0.29
$0.37
52 Week High
$6.89
$2.75

Technical Indicators

Market Signals
Indicator
DTCK
GOVX
Relative Strength Index (RSI) 39.40 29.98
Support Level $0.33 $0.37
Resistance Level $0.41 $0.41
Average True Range (ATR) 0.07 0.03
MACD 0.02 0.00
Stochastic Oscillator 10.45 1.01

Price Performance

Historical Comparison
DTCK
GOVX

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: